T1	Participants 170 235	serious mental illness (SMI) receiving antipsychotic drug therapy
T2	Participants 521 554	30 individuals (BMI â‰¥ 28 kg/m(2))
T3	Participants 464 499	weight loss in individuals with SMI
T4	Participants 1331 1372	patients taking antipsychotic medications
